Difference between revisions of "Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5 (Q9874)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: DOI Identifier (P138): 10.1021/ml1000307, #quickstatements; #temporary_batch_1590000649558)
(‎Created claim: Page(s) (P105): 130-134, #quickstatements; #temporary_batch_1590074839150)
 
(5 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 24900187 / rank
 +
Normal rank
Property / Publication Date
 +
2010
Timestamp+2010-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2010 / rank
 +
Normal rank
Property / Published In Name String
 +
ACS Med. Chem. Lett.
Property / Published In Name String: ACS Med. Chem. Lett. / rank
 +
Normal rank
Property / Volume
 +
1
Property / Volume: 1 / rank
 +
Normal rank
Property / title
 +
Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English)
Property / title: Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English) / rank
 +
Normal rank
Property / Page(s)
 +
130-134
Property / Page(s): 130-134 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Pan S
    0 references
    0 references
    2010
    0 references
    ACS Med. Chem. Lett.
    0 references
    1
    0 references
    Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English)
    0 references
    130-134
    0 references